FOXP3 and myeloid sarcoma: Along similar lines, weaker FoxP3+ expression was detected in children with MS in whom the ability to suppress CD4+CD25−CD127+ responder T cells and CD4+CCR2+CCR5+ Teff was worse than in HCs [20].